TheraTarget, Inc. is a biopharmaceutical company based in Salt Lake City, Utah, specializing in the development of polymer-drug conjugate delivery systems for clinical use. With a patented drug delivery platform, TheraTarget's innovative technology has shown promising results in preclinical testing, demonstrating high response rates, immunoactivation, and long-term suppression of tumor recurrence in solid tumors.
Driven by a mission to optimize immunotherapy, TheraTarget's management team and board of directors bring decades of expertise in polymer therapeutics, nanomedical applications, product development, manufacturing, quality control monitoring, and successful completion of clinical trials. In addition to cancer treatment, TheraTarget's pipeline includes preclinically proven agents for neuromodulation, showcasing the company's commitment to advancing medical solutions in various clinical arenas.
Generated from the website